NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

CEAT's Strong Q4 Performance Overshadowed by Challenging Near-Term Outlook

CEAT has reported a robust Q4, driven by a significant 18% year-over-year (YoY) growth in revenue across its replacement, OEM, and international segments. The company's earnings before interest, taxes, depreciation, and amortization (EBITDA) saw a substantial 49% YoY increase, with the margin expanding by 50 basis points (bps) quarter-over-quarter (QoQ) to 14.6%.

However, the near-term outlook appears challenging, particularly in the first half of financial year 2027 (H1FY27). The management expects a further ~15-20% rise in raw material (RM) prices in Q1FY27 compared to Q4FY26. To mitigate this sharp inflation, the company has implemented ~5% price hikes in March 2026, with additional 5% hikes planned for May and June. While this move is likely to drive value-led growth in FY27, it raises concerns about the quantum of cost passthrough in a competitive setup, which could negatively impact demand and margin.

CAMSO's Growth Expected to be Back-Ended

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The ongoing transition phase is expected to result in cost pressures persisting through to FY27, with meaningful margin benefits likely to flow only in FY28E. As a result, CEAT's growth for CAMSO is anticipated to be back-ended.

Downgrade and Target Price Revision

Considering the challenging near-term outlook, we have revised our estimates for CEAT's earnings per share (EPS) for FY27E and FY28E. We have slashed our EPS estimates by ~47% and ~17%, respectively, factoring in a sharp margin reset from 12.3% and 13.3% earlier to 9.6% and 12% now. Based on this revised assessment, we downgrade CEAT to REDUCE from Buy and cut our target price by ~27% to Rs3,600 from Rs4,900, valuing the stock at 20x March 2028E EPS.

Revised Estimates Comparison

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Original EstimateRevised Estimate
FY27E EPS12.3%9.6%
FY28E EPS13.3%12%
Target PriceRs4,900Rs3,600

Investor Takeaway

Investors should be cautious of the near-term outlook for CEAT due to expected inflation and potential impact on demand and margins.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.